Clinical Trial Update: A Trial of ALB 109564(a) in Subjects With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This entry reports that the Phase 1 trial of ALB 109564(a) in subjects with advanced solid tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• ALB 109564(a)

Snippet

Sponsor: Albany Molecular Research, Inc. | Conditions: Cancer | Phase 1 | Status: TERMINATED